Karyopharm Therapeutics logo
Karyopharm Therapeutics
KPTI | NASDAQ
Chart Builder DCF Calculator
$0.11
-$0.55 (-83.38%)
At close: Nov 2, 2026, 4:00 PM ET

Karyopharm Therapeutics Cash Flow Statement

Cash flow statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
-196.04M -76.42M -143.1M -165.29M -124.09M -196.27M
296K 340K 530K 621K 789K 972K
14.05M 18.43M 21.71M 35.4M 29.78M 24.41M
24.09M 3.21M 9.76M -15.96M -9.26M 5.54M
78.05M -69.53M -3.28M -294K 8.14M 8.4M
– – – – 1.45M 904K
28.27M -302K 31.42M -19.99M -23.19M 1.36M
-75.37M -127.49M -92.72M -149.55M -107.12M -160.23M
– -142K – -118K -5.71M -145K
– – – 104.26M 5.5M 53.54M
– -58.82M -159.15M -226.02M -45.23M -274.58M
43.38M 154.44M 167.09M 121.88M 192.78M 221.04M
– – – -104.26M -5.5M -53.54M
43.38M 95.47M 7.94M -104.26M 141.84M -53.69M
20.54M 83.3M – – 60M –
– – – – – –
– – – – – –
– -43.11M – 3.98M 3.75M 10.31M
30.05M 41.65M 1.12M 193.74M 73.65M 172.08M
-1.92M 9.62M -83.69M -60.56M 108.32M -41.57M
-75.37M -127.63M -92.72M -149.67M -112.83M -160.38M
-89.42M -146.05M -114.43M -185.07M -142.61M -184.79M
– -142K – -118K – –
– – – – -5.71M -145K
-75.37M -127.63M -92.72M -149.67M -107.12M -160.23M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.